Red X iconGreen tick iconYellow tick icon

Contact Details

+64 3 479 7240
Associate Professor in Clinical Pharmacology and Associate Dean Research
BSc(Hons)(Aberd) PhD(Glas)
Research summary
Neuropharmacology, neurodegeneration and repair
Basic and Clinical Pharmacology
Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
A randomized trial of varenicline for the treatment of cognitive and effective symptoms in Huntington’s Disease (VCAS-HD), funded by The New Zealand Pharmacy Education and Research Fund and The Oakley Mental Health Foundation.


My area of interest is neurodegenerative diseases, neuroprotection and repair, in particular the development of disease models with clinically relevant endpoints as a basis for investigating potential therapies.

My research focuses on pharmacological enhancement of motor recovery after stroke and cholinergic dysfunction in Huntington's Disease and vascular dementia.


Nair, S., Yin, E., Smith, A., & McGregor, A. (2022, November). Exposure to antipsychotic medication is detrimental to the functional status of NZ stroke patients. Verbal presentation at the School of Pharmacy Research Day, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Hounsell, J., Liebergreen, N., King, M., & McGregor, A. L. (2022). Exploring the awareness of people affected by Huntington's disease towards regenerative therapies. New Zealand Medical Journal, 135(1557), (pp. 103). Retrieved from Conference Contribution - Published proceedings: Abstract

Chen, S., Bennet, L., & McGregor, A. L. (2022). Delayed citalopram administration reduces brain inflammation and enhances skilled motor function after ischaemic stroke in 'MacGreen' mice. European Journal of Neuroscience, 55, 1344-1355. doi: 10.1111/ejn.15601 Journal - Research Article

McGregor, A. L., Hoque, M. R., Nickel, S., Smith, A. J., & Atiquzzaman, M. (2022). Anti-epileptic medication exposure influences functional status in New Zealand stroke patients: A retrospective population-level study. Drugs: Real World Outcomes, 9, 165-173. doi: 10.1007/s40801-021-00280-5 Journal - Research Article

Nair, S., Chen, S., Gupta, D., Smith, A. J., & McGregor, A. L. (2021). Higher BMI confers a long-term functional status advantage in elderly New Zealand European stroke patients. Journal of Stroke & Cerebrovascular Diseases, 30(5), 105711. doi: 10.1016/j.jstrokecerebrovasdis.2021.105711 Journal - Research Article

Back to top